January 20, 2026
Letrozole with IUI Pregnancy Rates: Key Study Findings Revealed
A 2016 ASRM study analyzed 533 letrozole-IUI cycles and found that a 5mm endometrial lining achieved the same 17% clinical pregnancy rate as thicker linings. Dr. Kate Devine highlights follicle count and sperm motility as critical success factors.
Key Takeaways
Letrozole vs. Clomid: Impact on Endometrial Thickness
Letrozole is preferred over clomiphene citrate (Clomid) for preserving endometrial lining thickness, as Clomid often causes thinning. This study confirmed letrozole’s effectiveness in maintaining adequate lining for implantation.
Optimal Lining Thickness for Letrozole-IUI Cycles
Pregnancy rates plateau at 17% for linings ≥5mm, debunking the myth that thicker linings (e.g., 9mm) significantly improve outcomes. This lowers the threshold for achieving viable implantation conditions.
Follicle Count and Sperm Quality as Predictive Factors
The study identified follicle count (≥2 follicles) and total motile sperm count (>5 million) as key predictors of success, emphasizing their importance alongside lining thickness in treatment planning.
Clinical Implications for Low-Tech Fertility Treatments
Patients using letrozole-IUI should prioritize achieving a ≥5mm lining, with additional focus on optimizing follicular development and sperm quality to maximize pregnancy chances.
Evidence-Based Guidance for ASRM 2016 Study Participants
Presented at the 2016 ASRM Congress, the findings provide actionable insights for clinicians and patients, shifting focus from excessive lining growth to balanced hormonal and reproductive parameters.
Source: Read full article